Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.54%
#6 Wrapped Krown Wrapped Krown +20.00%
#7 Talus Network Talus Network +19.98%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 Magma Finance Magma Finance +14.74%
Coin of the day
DeFiChain DeFiChain
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Rang în acțiuni #16324
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Preț acțiune
$0.94180721
Capitalizare de piață
$22.26M
Schimbare (1 zi)
0.38%
Schimbare (1 an)
-14.35%
Țară
FR
Tranzacționează Valbiotis SA (ALVAL)

Categorie

Healthcare
Raport P/S pentru Valbiotis SA (ALVAL)
Raport P/S la data de July 2026 TTM: 20.66
Conform celor mai recente rapoarte financiare și prețului acțiunilor Valbiotis SA, raportul P/S actual (TTM) este 20.66. La sfârșitul anului 2023, compania avea un P/S de 13.17.
Istoricul raportului P/S pentru Valbiotis SA din 2015 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 20.66 -84.94%
2024 137.18 942.04%
2023 13.17 -71.62%
2022 46.39 -77.96%
2021 210.51 1,341.15%
2020 14.61 -87.37%
2019 115.65 -24.97%
2018 154.14 -97.25%
2017 5.61K 10,113.84%
2016 54.92 355.39%
2015 12.06 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.33 -79.03%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.86 -52.26%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.53 -78.07%
US
UCB SA UCB SA
UCB SA
UCB.BR
5.72 -72.33%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.03 -22.43%
NL